ERIN AFABLE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family WESTLAKE, OH NPI 1114677697

General Payments — all program years on this page

$929.76

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 44
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $358.47 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $358.4719

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $29.392
2023 $541.9023
2024 $358.4719

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086687895 Novartis Pharmaceuticals Corporation $32.26 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086687903 Novartis Pharmaceuticals Corporation $24.65 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105455041 AstraZeneca Pharmaceuticals LP $19.00 11/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105477865 AstraZeneca Pharmaceuticals LP $19.53 08/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105744168 AstraZeneca Pharmaceuticals LP $20.83 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114264026 Regeneron Healthcare Solutions, Inc. $13.69 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114264028 Regeneron Healthcare Solutions, Inc. $15.03 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114264030 Regeneron Healthcare Solutions, Inc. $14.81 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114264032 Regeneron Healthcare Solutions, Inc. $17.39 11/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115410236 Amgen Inc. $15.62 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115410240 Amgen Inc. $16.15 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116152366 GlaxoSmithKline, LLC. $13.32 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116240807 GlaxoSmithKline, LLC. $24.07 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116241145 GlaxoSmithKline, LLC. $14.50 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116552741 GlaxoSmithKline, LLC. $27.97 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131322672 PFIZER INC. $19.31 04/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133158135 Genentech USA, Inc. $13.13 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133158139 Genentech USA, Inc. $17.21 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139888442 GENZYME CORPORATION $20.00 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.